Literature DB >> 9276718

The critical early proinflammatory events associated with idiopathic pneumonia syndrome in irradiated murine allogeneic recipients are due to donor T cell infusion and potentiated by cyclophosphamide.

A Panoskaltsis-Mortari1, P A Taylor, T M Yaeger, O D Wangensteen, P B Bitterman, D H Ingbar, D A Vallera, B R Blazar.   

Abstract

We have hypothesized that lung damage occurring in the peri-bone marrow transplant (BMT) period is critical for the subsequent generation of idiopathic pneumonia syndrome (IPS), a major complication following human BMT. The proinflammatory events induced by a common pre-BMT conditioning regimen, cyclophosphamide (Cytoxan(R)) (Cy) and total body irradiation, were analyzed in a murine BMT model. Electron microscopy indicated that Cy exacerbated irradiation-induced epithelial cell injury as early as day 3 after BMT. Allogenicity was an important contributing factor to lung injury as measured by lung wet and dry weights and decreased specific lung compliance. The most significant pulmonary dysfunction was seen in mice receiving both allogeneic T cells and Cy conditioning. IPS was associated with an influx of T cells, macrophages, and neutrophils early post-BMT. Hydroxyproline levels were not increased, indicating that the injury was not fibrotic early post-BMT. As early as 2 h after chemoradiation, host macrophages increased in number in the lung parenchyma. Continued increases in macrophages occurred if splenic T cells were administered with the donor graft. The expression of costimulatory B7 molecules correlated with macrophage numbers. Frequencies of cells expressing mRNA for the inflammatory proteins TNF-alpha, IL-1beta, and TGFbeta were increased. Cy accelerated the upregulation of TGFbeta and increase in host macrophages. The exacerbation of macrophage activation and severity of IPS was dependent on allogeneic T cells, implicating immune-mediated mechanisms as critical to the outcome of IPS. This demonstration of early injury after BMT indicates the need for very early therapeutic intervention before lung damage becomes profound and irreversible.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9276718      PMCID: PMC508276          DOI: 10.1172/JCI119612

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  60 in total

1.  A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Lung Rejection Study Group. The International Society for Heart Transplantation.

Authors:  G J Berry; E M Brunt; D Chamberlain; R H Hruban; R K Sibley; S Stewart; H D Tazelaar
Journal:  J Heart Transplant       Date:  1990 Nov-Dec

2.  Cytokine networks in the regulation of inflammation and fibrosis in the lung.

Authors:  J A Elias; B Freundlich; J A Kern; J Rosenbloom
Journal:  Chest       Date:  1990-06       Impact factor: 9.410

3.  Transforming growth factor-beta production by lung macrophages and fibroblasts.

Authors:  J Kelley; E J Kovacs; K Nicholson; J P Fabisiak
Journal:  Chest       Date:  1991-03       Impact factor: 9.410

4.  Increased serum levels of tumor necrosis factor alpha precede major complications of bone marrow transplantation.

Authors:  E Holler; H J Kolb; A Möller; J Kempeni; S Liesenfeld; H Pechumer; W Lehmacher; G Ruckdeschel; B Gleixner; C Riedner
Journal:  Blood       Date:  1990-02-15       Impact factor: 22.113

5.  Allogeneic marrow transplantation in patients with acute myeloid leukemia in first remission: a randomized trial of two irradiation regimens.

Authors:  R A Clift; C D Buckner; F R Appelbaum; S I Bearman; F B Petersen; L D Fisher; C Anasetti; P Beatty; W I Bensinger; K Doney
Journal:  Blood       Date:  1990-11-01       Impact factor: 22.113

6.  Determination of 3- and 4-hydroxyproline.

Authors:  R A Berg
Journal:  Methods Enzymol       Date:  1982       Impact factor: 1.600

7.  Pulmonary toxicity of cyclophosphamide: a 1-year study.

Authors:  C C Morse; C Sigler; S Lock; P J Hakkinen; W M Haschek; H P Witschi
Journal:  Exp Mol Pathol       Date:  1985-04       Impact factor: 3.362

8.  Radiation effects on mouse incisor teeth following whole-body doses of up to 16 gray.

Authors:  A E Pearson; T A Phelps
Journal:  Int J Radiat Biol Relat Stud Phys Chem Med       Date:  1981-04

9.  Long-term morphologic and biochemical features of experimentally induced lung fibrosis in the mouse.

Authors:  W M Haschek; A J Klein-Szanto; J A Last; K M Reiser; H Witschi
Journal:  Lab Invest       Date:  1982-04       Impact factor: 5.662

10.  Bleomycin-induced changes in pulmonary microvascular albumin permeability and extravascular albumin space.

Authors:  D Wangensteen; R Yankovich; J Hoidal; D Niewoehner
Journal:  Am Rev Respir Dis       Date:  1983-02
View more
  29 in total

1.  Club cell secretory protein improves survival in a murine obliterative bronchiolitis model.

Authors:  Christine Wendt; Kevin Tram; Andrew Price; Kristen England; Andrew Stiehm; Angela Panoskaltsis-Mortari
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-08-30       Impact factor: 5.464

2.  Decreased asbestos-induced lung inflammation and fibrosis after radiation and bone marrow transplant.

Authors:  Jamie Levis; Roberto Loi; Kelly J Butnor; Pamela Vacek; Chad Steele; Brooke T Mossman; Daniel J Weiss
Journal:  Am J Respir Cell Mol Biol       Date:  2007-08-02       Impact factor: 6.914

3.  Influence of oral beclomethasone dipropionate on early non-infectious pulmonary outcomes after allogeneic hematopoietic cell transplantation: results from two randomized trials.

Authors:  J W Chien; M Sakai; T A Gooley; H G Schoch; G B McDonald
Journal:  Bone Marrow Transplant       Date:  2009-06-29       Impact factor: 5.483

Review 4.  An official American Thoracic Society research statement: noninfectious lung injury after hematopoietic stem cell transplantation: idiopathic pneumonia syndrome.

Authors:  Angela Panoskaltsis-Mortari; Matthias Griese; David K Madtes; John A Belperio; Imad Y Haddad; Rodney J Folz; Kenneth R Cooke
Journal:  Am J Respir Crit Care Med       Date:  2011-05-01       Impact factor: 21.405

5.  Prevention of GVHD while sparing GVL effect by targeting Th1 and Th17 transcription factor T-bet and RORγt in mice.

Authors:  Yu Yu; Dapeng Wang; Chen Liu; Kane Kaosaard; Kenrick Semple; Claudio Anasetti; Xue-Zhong Yu
Journal:  Blood       Date:  2011-08-19       Impact factor: 22.113

6.  First-Onset Herpesviral Infection and Lung Injury in Allogeneic Hematopoietic Cell Transplantation.

Authors:  Xiaofeng Zhou; David N O'Dwyer; Meng Xia; Holly K Miller; Paul R Chan; Kelsey Trulik; Mathew M Chadwick; Timothy C Hoffman; Camille Bulte; Kevin Sekerak; Carol A Wilke; Swapneel J Patel; Wayne M Yokoyama; Susan Murray; Gregory A Yanik; Bethany B Moore
Journal:  Am J Respir Crit Care Med       Date:  2019-07-01       Impact factor: 21.405

7.  A new murine model for bronchiolitis obliterans post-bone marrow transplant.

Authors:  Angela Panoskaltsis-Mortari; Kevin V Tram; Andrew P Price; Christine H Wendt; Bruce R Blazar
Journal:  Am J Respir Crit Care Med       Date:  2007-06-15       Impact factor: 21.405

8.  The impact of soluble tumor necrosis factor receptor etanercept on the treatment of idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell transplantation.

Authors:  Gregory A Yanik; Vincent T Ho; John E Levine; Eric S White; Thomas Braun; Joseph H Antin; Joel Whitfield; Joseph Custer; Dawn Jones; James L M Ferrara; Kenneth R Cooke
Journal:  Blood       Date:  2008-07-29       Impact factor: 22.113

9.  Simultaneous absence of surfactant proteins A and D increases lung inflammation and injury after allogeneic HSCT in mice.

Authors:  Kendra Gram; Shuxia Yang; Marie Steiner; Arif Somani; Samuel Hawgood; Bruce R Blazar; Angela Panoskaltsis-Mortari; Imad Y Haddad
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-11-07       Impact factor: 5.464

10.  A role for TNF receptor type II in leukocyte infiltration into the lung during experimental idiopathic pneumonia syndrome.

Authors:  Gerhard C Hildebrandt; Krystyna M Olkiewicz; Leigh Corrion; Shawn G Clouthier; Elizabeth M Pierce; Chen Liu; Kenneth R Cooke
Journal:  Biol Blood Marrow Transplant       Date:  2008-04       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.